Quell Therapeutics Limited
Clinical trials sponsored by Quell Therapeutics Limited, explained in plain language.
-
Engineered immune cells take on tough autoimmune diseases
Disease control Recruiting nowThis early-stage trial tests an experimental treatment called QEL-005 for people with two serious autoimmune conditions: diffuse cutaneous systemic sclerosis and difficult-to-treat rheumatoid arthritis. QEL-005 is made from a patient's own white blood cells, which are genetically…
Phase: PHASE1, PHASE2 • Sponsor: Quell Therapeutics Limited • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Blood cell collection could pave way for new immune therapies
Knowledge-focused Recruiting nowThis study collects white blood cells from up to 10 healthy volunteers and patients with autoimmune diseases, inflammation, or liver transplant. The goal is to analyze these cells to help develop engineered regulatory T cell (Treg) therapies. No treatment is given; it is a resear…
Sponsor: Quell Therapeutics Limited • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC